Combining data from various mutant studies, we propose that E256/E442/E443 of GCK are involved in L-arginine-binding as well as L-arginine-induced insulin secretion, providing a molecular mechanism by which E256K and E442* mutations lead to MODY2. This evidence concerns the gene GCK and maturity-onset diabetes of the young type 2.